Speaker Profile

Vice President, Public Affairs, Guardant Health

Jenn Higgins is responsible for leading and directing the overall government affairs, patient advocacy, public policy, and corporate communications functions for Guardant Health (NASDAQ: GH). As a veteran of Washington DC, Jenn serves as the company’s point of contact with Congress and the Administration, actively working with key health care stakeholders to help shape public debate around issues that matter to Guardant Health. Jenn has spent the past twenty years using her tenacity and policy knowledge to help corporate executives navigate a constantly changing legislative and regulatory landscape. As a lobbyist, Jenn has represented a wide variety of Fortune 500 health care companies before Congress and the Administration, serving as Partner with two prominent lobbying firms. She also worked as an analyst and Special Assistant at the Centers for Medicare & Medicaid Services, with an emphasis on Medicare policy. Jenn attended Davidson College where she received a B.A. in Medical Economics and Ethics.

 Session Abstract – PMWC 2022 Silicon Valley

Track 3, June 28

Precision medicine is among the key contributors in progressing cancer survivorship. However, biomarker testing, which is critical to enabling precision medicine treatments, is below guideline recommendations due to various factors. The session will discuss these barriers, as well as bringing tangible and sustainable solutions to patients with cancer through collaboration.